OVEREXPRESSION OF P53 IN HEAD AND NECK-CANCER

被引:87
作者
WATLING, DL
GOWN, AM
COLTRERA, MD
机构
[1] UNIV WASHINGTON,DEPT OTOLARYNGOL HEAD & NECK SURG RL30,SEATTLE,WA 98195
[2] UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 1992年 / 14卷 / 06期
关键词
D O I
10.1002/hed.2880140603
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The putative tumor suppressor gene p53 plays a key role in the regulation of cell proliferation. Functional loss of p53 protein through mutation or viral oncogene-complexing can result in p53 protein overexpression detectable by immunocytochemistry, which in turn has been associated with markers of poor prognosis in some cancers. We report here an analysis of p53 overexpression in fixed, embedded specimens from 81 prospectively collected head and neck tumors, both benign and malignant, including 55 squamous cell carcinomas, using monoclonal pAb1801. Sixty-two percent of the squamous cell carcinomas from the head and neck region overexpressed p53, whereas none of the benign tumors or adjacent normal tissues overexpressed p53. Overexpression of p53 was strongly associated (p < 0.01, two-tailed chi-square) with a histologic malignancy grading scale previously shown to have prognostic capabilities. We conclude that p53 overexpression is one of the most common abnormalities identified in head and neck cancer, and may be a useful marker in the study of multistep progression of tumorigenesis.
引用
收藏
页码:437 / 444
页数:8
相关论文
共 32 条
[1]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[2]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[3]   ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION [J].
BANKS, L ;
MATLASHEWSKI, G ;
CRAWFORD, L .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03) :529-534
[4]  
BARTEK J, 1990, ONCOGENE, V5, P893
[5]  
BLANTON BA, 1991, J CELL BIOL, V5, pA207
[6]   GENETIC AND CELLULAR BASIS OF MULTISTEP CARCINOGENESIS [J].
BOYD, JA ;
BARRETT, JC .
PHARMACOLOGY & THERAPEUTICS, 1990, 46 (03) :469-486
[7]  
BRAITHWAITE AW, 1991, ONCOGENE, V6, P781
[8]   P53 EXPRESSION IN BREAST-CANCER [J].
CATTORETTI, G ;
RILKE, F ;
ANDREOLA, S ;
DAMATO, L ;
DELIA, D .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) :178-183
[9]   LOSS OF HETEROZYGOSITY ON THE SHORT ARM OF CHROMOSOME-17 IS ASSOCIATED WITH HIGH PROLIFERATIVE CAPACITY AND DNA ANEUPLOIDY IN PRIMARY HUMAN BREAST-CANCER [J].
CHEN, LC ;
NEUBAUER, A ;
KURISU, W ;
WALDMAN, FM ;
LJUNG, BM ;
GOODSON, W ;
GOLDMAN, ES ;
MOORE, D ;
BALAZS, M ;
LIU, E ;
MAYALL, BH ;
SMITH, HS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) :3847-3851
[10]   FREQUENT MUTATIONS IN THE P53 TUMOR SUPPRESSOR GENE IN HUMAN LEUKEMIA T-CELL LINES [J].
CHENG, J ;
HAAS, M .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (10) :5502-5509